By Stephanie Eloisa D. Miaco, M.D.
HealthxPH partners with the PsorPhil Group c/o Mr. Paul Mendoza and Dr. Gia Sison for this week’s special edition TweetChat.
This effort is to bring to light to the wider online audience a very important psychosocial issue of depression and suicidal tendencies in patients diagnosed with Psoriasis.
Psoriasis is a chronic skin condition affecting approximately 2-3% of the U.S. and the worldwide population. It affects not only the physical health of patients, but also their psychosocial well-being and overall quality of life. However, sparse information is available regarding mental health issues in individuals with psoriasis.
Some studies have shown that elevated levels of inflammatory cytokines have been found in the blood and cerebrospinal fluid of patients who either attempted or committed suicide, indicating a possible role of inflammation in the development of depression and suicidality. A study by Wu, JJ, et al.,2017, analyzed 36, 214 psoriasis patients, and their study revealed that there was indeed a correlation between psoriasis and depression.
In this event, we would like to reach major stakeholders amongst the participants:
Health care professionals (i.e. Physicians, nurses,paramedical professionals, etc) who can benefit from the update by learning more about diagnostics and management of individuals with Psoriasis.
Researchers so they can be more aware of knowledge gaps to fill;
Health Policy Sectors so they can commit their efforts into coming up with beneficial programs
Friends and family caregivers of individuals diagnosed with Psoriasis, so that they can further their knowledge and empathize to improve their care.
We at #Healthxph believe in changing person’s healthcare attitudes and behavior through information and social media and we would like to invite you to take part in the discussion, with the following guide questions for our participants tonight:
T1: What are the experiences and challenges with healthcare for individuals diagnosed with Psoriasis?
T2: What challenges diagnosis and management of depression and suicidal tendencies in individuals with Psoriasis?
T3: How can we contribute to alleviating these challenges?